CK-MB is Not Appropriate for Chronic Chest Pain
In patients with stable chest pain lasting over three months, CK-MB testing should not be ordered—it provides no diagnostic or prognostic value in this setting. 1, 2
Why CK-MB is Inappropriate for Chronic Chest Pain
Timing and Kinetics Make CK-MB Irrelevant
CK-MB is designed to detect acute myocardial necrosis occurring within hours to days, not chronic conditions:
- CK-MB rises 3-4 hours after acute myocardial injury and returns to baseline within 48-72 hours 3, 4
- In chronic stable chest pain (>3 months), any acute event would have resolved long ago, making CK-MB levels meaningless
- CK-MB has been completely superseded by cardiac troponins for detecting myocardial injury 1, 2
Guidelines Explicitly State CK-MB is Obsolete
The 2014 AHA/ACC guidelines definitively state: "With the availability of cardiac troponin, CK-MB, myoglobin, and other diagnostic biomarkers are no longer necessary." 1, 2 This applies even more strongly to chronic presentations where acute injury is not suspected.
The only remaining limited uses for CK-MB are:
- Estimating infarct size in acute MI 1
- Detecting reinfarction in patients with recent (<2 weeks) MI when troponin remains elevated 3, 4
Neither scenario applies to chronic stable chest pain.
What You Should Order Instead
For Chronic Chest Pain Evaluation:
Cardiac troponin (preferably high-sensitivity) is the only biomarker that may be relevant, but even this has limited utility in truly chronic presentations 5:
- A normal troponin helps exclude ongoing myocardial injury
- An elevated troponin in chronic chest pain suggests chronic myocardial injury (not acute MI) and warrants further investigation for causes like heart failure, chronic kidney disease, or other cardiomyopathies 6
The Real Diagnostic Approach:
For stable chest pain >3 months without acute symptoms:
- Risk stratification based on clinical history and cardiovascular risk factors
- Resting ECG to identify baseline abnormalities
- Functional or anatomical testing (stress testing, coronary CT angiography) based on pre-test probability—not biomarkers 1, 2, 5
- Consider troponin only if there's concern for chronic myocardial injury from non-ischemic causes
Common Pitfalls to Avoid
Reflexive ordering of "cardiac enzymes" is wasteful and potentially misleading 7:
- A 2014 audit found 93.8% of cardiac marker requests were inappropriate, with clinicians ordering CK-MB when only troponin was indicated 7
- CK-MB adds zero diagnostic value when troponin is negative 8, 9
- False-positive CK-MB (from skeletal muscle injury, renal failure) can lead to unnecessary interventions 3
In chronic chest pain, CK-MB will be normal regardless of whether significant coronary disease is present, making it completely uninformative for your clinical decision-making.